Schizophrenia: Illuminating a potential treatment and gene regulation

A new study from the lab of Waisman investigator Xinyu Zhao, PhD, brings us one step closer to identifying treatments for psychiatric disorders like schizophrenia (SCZ) and illuminates the role of a specific gene in regulating the disorder.  “Regulation of Cav3.2 by schizophrenia risk gene FXR1 is critical for interneuron functions and social behaviors” was published in the journal Molecular Psychiatry in April. The study also identifies a specific gene as the regulator of a type of neurons that plays a critical role in the pathogenesis of certain psychiatric disorders.